SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 353 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $7,270,000 | +2275.8% | 55,000 | +431.4% | 0.46% | +2455.6% |
| Q1 2017 | $306,000 | +7.7% | 10,350 | 0.0% | 0.02% | -47.1% |
| Q4 2016 | $284,000 | -92.0% | 10,350 | -82.1% | 0.03% | -86.5% |
| Q3 2016 | $3,556,000 | +1170.0% | 57,900 | +293.9% | 0.25% | +769.0% |
| Q2 2016 | $280,000 | -70.7% | 14,700 | -70.0% | 0.03% | -60.8% |
| Q1 2016 | $956,000 | -36.5% | 48,971 | +25.6% | 0.07% | -69.9% |
| Q4 2015 | $1,505,000 | – | 39,000 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,195,000 | $142,432,000 | 6.16% |
| Casdin Capital, LLC | 305,000 | $36,353,000 | 3.99% |
| Eventide Asset Management | 845,168 | $100,736,000 | 3.47% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 436,000 | $51,967,000 | 3.26% |
| NEXTHERA CAPITAL LP | 21,270 | $2,535,000 | 3.08% |
| Camber Capital Management LP | 500,000 | $59,595,000 | 2.97% |
| Eversept Partners, LP | 83,574 | $9,961,185 | 2.91% |
| CADIAN CAPITAL MANAGEMENT, LP | 610,546 | $72,771,000 | 2.84% |
| RTW INVESTMENTS, LP | 338,199 | $40,310,000 | 2.75% |
| Cormorant Asset Management, LP | 300,000 | $35,757,000 | 2.42% |